Debra Wu
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
Papers in
-
- Nanoparticle-Based Drug Delivery 4
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Samir MitragotriAnusha PusuluriC. Wyatt ShieldsLiwen WangZongmin ZhaoDaniel C. PanJunling GuoAnvay Ukidve
- Journals
- Bioengineering & Translational Medicine (3 papers)Pharmaceutics (2 papers)Journal of Controlled Release (2 papers)ACS Biomaterials Science & Engineering (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Debra Wu
12 papers receiving 908 citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Biomaterials 292
- Immunology 251
- Biomedical Engineering 381
- Pharmaceutical Science 49
- Molecular Biology 385
Countries citing papers authored by Debra Wu
This map shows the geographic impact of Debra Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Wu more than expected).
Fields of papers citing papers by Debra Wu
This network shows the impact of papers produced by Debra Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Wu. The network helps show where Debra Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Debra Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2021 | 4 | |
| 3 | Cellular backpacks for macrophage immunotherapy Hit paper breakdown → | 2020 | 319 |
| 4 | 2020 | 42 | |
| 5 | 2020 | 147 | |
| 6 | 2020 | 27 | |
| 7 | 2020 | 25 | |
| 8 | 2020 | 135 | |
| 9 | 2020 | 111 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 50 | |
| 12 | 2019 | 29 |
About Debra Wu
Debra Wu is a scholar working on Biomaterials, Oncology, Catalysis, Immunology and Neurology, having authored 12 papers that have together received 920 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Innovative Microfluidic and Catalytic Techniques Innovation (1 paper) and Barrier Structure and Function Studies (1 paper). The work is most often cited by research in Biomaterials (292 citations), Immunology (251 citations), Biomedical Engineering (381 citations), Pharmaceutical Science (49 citations) and Molecular Biology (385 citations). Debra Wu has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Samir Mitragotri, Anusha Pusuluri, C. Wyatt Shields, Liwen Wang, Zongmin Zhao, Daniel C. Pan, Junling Guo, Anvay Ukidve, Michael A. Evans and Neil J. Baugh. Their work appears in journals such as Bioengineering & Translational Medicine, Pharmaceutics, Journal of Controlled Release, ACS Biomaterials Science & Engineering and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.